Volume 67, Issue 6, Pages (June 2005)

Slides:



Advertisements
Similar presentations
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Advertisements

Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Volume 60, Issue 3, Pages (September 2001)
Volume 94, Issue 3, Pages (September 2018)
Osteopontin expression in acute renal allograft rejection
Volume 79, Issue 1, Pages (January 2011)
Volume 68, Issue 6, Pages (December 2005)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 79, Issue 2, Pages (January 2011)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Testosterone promotes apoptotic damage in human renal tubular cells
Volume 82, Issue 6, Pages (September 2012)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 85, Issue 1, Pages (January 2014)
Volume 72, Issue 4, Pages (August 2007)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
Volume 65, Issue 2, Pages (February 2004)
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Volume 83, Issue 3, Pages (March 2013)
Volume 68, Issue 5, Pages (November 2005)
Volume 88, Issue 3, Pages (September 2015)
Volume 82, Issue 10, Pages (November 2012)
Genistein protects the kidney from cisplatin-induced injury
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 58, Issue 4, Pages (October 2000)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Volume 79, Issue 1, Pages (January 2011)
Volume 73, Issue 4, Pages (February 2008)
Volume 65, Issue 6, Pages (June 2004)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 82, Issue 9, Pages (November 2012)
Volume 63, Issue 2, Pages (February 2003)
Autophagy in proximal tubules protects against acute kidney injury
Inhibition of glomerular cell apoptosis by heparin
Volume 61, Issue 2, Pages (February 2002)
Volume 60, Issue 3, Pages (September 2001)
Volume 80, Issue 12, Pages (December 2011)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Volume 66, Issue 6, Pages (December 2004)
Volume 72, Issue 3, Pages (August 2007)
Volume 60, Issue 6, Pages (December 2001)
Tight blood pressure control decreases apoptosis during renal damage
Volume 83, Issue 3, Pages (March 2013)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 73, Issue 12, Pages (June 2008)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 65, Issue 5, Pages (May 2004)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 68, Issue 6, Pages (December 2005)
Volume 85, Issue 4, Pages (April 2014)
The pathological role of Bax in cisplatin nephrotoxicity
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 88, Issue 4, Pages (October 2015)
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials  Christof Westenfelder, Florian E. Togel 
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 67, Issue 4, Pages (April 2005)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 67, Issue 6, Pages 2210-2220 (June 2005) Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70  Satoshi Suzuki, Shoichi Maruyama, Waichi Sato, Yoshiki Morita, Fumihiko Sato, Yusuke Miki, Sawako Kato, Masahisa Katsuno, G.E.N. Sobue, Yukio Yuzawa, Seiichi Matsuo  Kidney International  Volume 67, Issue 6, Pages 2210-2220 (June 2005) DOI: 10.1111/j.1523-1755.2005.00326.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Induction of heat shock proteins (HSPs) at 24 hours after oral geranylgeranylacetone (GGA). (A) Dose-dependent expression of Hsp70 at 24 hours after oral GGA was analyzed by Western blot. Hsp70 expression increased significantly in rats given 400 mg/kg of GGA, but the dose of 800 mg/kg did not induce further increase. *P < 0.05 versus vehicle treated rats. (B) Immunohistochemistry revealed that a low level of Hsp70 expression was observed in the normal rat kidney. (C) GGA administration enhanced the expression of Hsp70 especially in the inner stripe of outer medulla. (D) The expression of other HSPs was also studied by Western blot. Hsp90, Hsc70, Hsp60 or Hsp32 was not induced in the kidney at 24 hours after administration GGA (400 mg/kg). Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 The time-course of heat shock protein (Hsp70) expression. The level of Hsp70 expression was studied at 12, 24, and 48 hours after a single oral dose of geranylgeranylacetone (GGA) (400 mg/kg). Hsp70 had started to increase by 12 hours, peaked at 24 hours, and had declined by 48 hours. No time-dependent change was observed in the expression of Hsp70 in the vehicle group. Hsp70 expression was also examined at 48 hours, after two oral doses (at 0 hour and 24 hours) of GGA (400 mg/kg). The peak level of Hsp70 expression was comparable to that induced by a single oral dose at 24 hours. Symbols are: vehicle (□); GGA (▪). *P < 0.05 versus vehicle-treated rats. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 The effect of quercetin pretreatment on the induction of heat shock protein (Hsp70). Quercetin pretreatment [Q +geranylgeranylacetone (GGA)] significantly suppressed the expression of Hsp70 in rat kidneys induced by GGA administration. *P < 0.05; **P < 0.01 versus rats treated with vehicle. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Histopathology. Sections from the vehicle-treated rats (A and D) showed tubular cast formation, tubular dilatation and tubular degeneration (vacuolar change, loss of brush border, detachment of tubular epithelial cells, and condensation of tubular nuclei) occurred mainly in the outer medulla of the kidney. Kidney sections from rats treated with geranylgeranylacetone (GGA) (B and E) showed only mild tubular damage. Pretreatment with quercetin cancelled the effects of GGA (C and F). (A through C) low-power (40×); (D through F) high-power (400×) views of the kidney section stained with periodic acid-Schiff (PAS). Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Tubular damage and macrophage infiltration. To assess the tubular injury and cast formation, kidney sections were analyzed using a semiquantitative grading. (A and B) Geranylgeranylacetone (GGA) treatment produced significantly better scores than vehicle treatment. (C) The number of ED-1–positive cells (macrophages) was also suppressed significantly by GGA administration. Quercetin pretreatment (Q + GGA) eliminated the effects of GGA. *P < 0.05; **P < 0.01. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Apoptotic cells in the kidney. (A) In the vehicle-treated rats, terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)-positive cells were localized mainly in the outer medulla. (B) In the geranylgeranylacetone (GGA)-treated rats, fewer apoptotic cells were observed. (D) The numbers of TUNEL-positive cells are expressed per 100 total tubular cells. GGA significantly suppressed apoptotic cell death of the tubules. (C and D) Quercetin pretreatment (Q + GGA) eliminated the effects of GGA. **P < 0.01. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Effects of geranylgeranylacetone (GGA) on renal function. Rats which underwent renal ischemic/reperfusion (I/R) (vehicle) exhibited significant increases in the levels of blood urea nitrogen (BUN) and serum creatinine at 24 hours after I/R injury. Preconditioning with GGA significantly suppressed these increases. Again, pretreatment with quercetin (Q + GGA) cancelled the renoprotective effect of GGA (A and B). Time course of renal function after I/R injury was also studied (C and D). Rats were treated with GGA (400 mg/kg) (N = 6) or a vehicle (N = 6) at 24 hours and 1 hour before the surgery, and blood samples were taken sequentially. Preconditioning with GGA significantly suppressed the increases in the levels of of BUN and serum creatinine. *P < 0.05; **P < 0.01. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Induction of heat shock protein (Hsp70) in rat primary cultures of tubular epithelial cells (R-TECs). Western blot analysis showed that 10 μmol/L geranylgeranylacetone (GGA) significantly enhanced Hsp70 expression. The result was not different from that observed after incubation with 100 μmol/L GGA (see Figure 7a and c). The time course analysis of Hsp70 expression demonstrated that 10 μmol/L GGA induced a transient increase in the protein level of Hsp70 in R-TECs, which peaked at 2 to 4 hours, followed by a rapid decline by 8 hours (see Figure 7b and d). The expression of other HSPs (Hsp90, Hsc70, Hsp60, and Hsp32) was not affected by GGA administration (see Figure 7e). **P < 0.01. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Apoptosis in rat primary cultures of tubular epithelial cells (R-TECs). R-TECs were incubated in culture medium containing 0.5 mmol/L hydrogen peroxide. A significant number of terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)-positive cells were observed in R-TECs treated with vehicle (A). Geranylgeranylacetone (GGA) preconditioning significantly attenuated the number of TUNEL-positive cells (B). The difference was statistically significant (C). A significant number of TUNEL-positive cells were also observed when R-TECs were treated in pharmacologic ischemia (D). GGA preconditioning significantly attenuated the number of TUNEL-positive cells (E and F). *P < 0.05; **P < 0.01. Kidney International 2005 67, 2210-2220DOI: (10.1111/j.1523-1755.2005.00326.x) Copyright © 2005 International Society of Nephrology Terms and Conditions